Skip to main content

Table 1 Baseline characteristics between patients with and without ISMN

From: Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

Variable

Without ISMN (n = 62)

With ISMN (n = 46)

P value

Baseline Demographics

Age, years

64.3 ± 10.1

65.0 ± 11.1

0.75

Male, n (%)

42(67.7)

31(86.1)

1.0

Body mass index, kg/m2

26.3 ± 3.9

25.0 ± 3.6

0.09

Hypertension, n (%)

15(24.2)

5(10.9)

0.09

Smoking, n (%)

29(46.8)

23(50.0)

0.70

Insulin therapy, n (%)

13(21.0)

7(15.2)

0.62

Creatinine, mmol/L

141.1 ± 137.4

128.8 ± 91.9

0.59

HbA1c, %

7.8 ± 2.6

7.8 ± 1.4

0.92

Total cholesterol, mmol/L

4.4 ± 1.0

4.5 ± 1.3

0.88

Triglyceride, mmol/L

1.9 ± 1.6

2.1 ± 4.0

0.76

HDL cholesterol, mmol/L

1.1 ± 0.2

1.2 ± 0.2

0.18

LDL cholesterol, mmol/L

2.6 ± 0.9

2.5 ± .7

0.76

Triple vessel disease, n (%)

3(4.8)

11(23.9)

*0.01

Prior myocardial infarction, n (%)

15(24.2)

18(39.1)

0.14

Prior PCI, n (%)

17(27.4)

18(39.1)

0.21

Drug eluting stent, n (%)

43(69.4)

31(67.4)

0.84

Impaired LVEF < 50%, n(%)

13(21.0)

7(15.2)

0.62

Medications after PCI

Beta blocker, n (%)

50(80.6)

38(82.6)

1.0

Calcium channel blocker, n (%)

43(69.4)

29(63.0)

0.40

Statin, n (%)

54(87.1)

41(89.1)

1.0

ACEI/ARB, n (%)

53(85.5)

39(84.8)

0.77

Aldosterone blocker, n (%)

6(9.7)

1(2.2)

0.14

  1. Abbreviation: ACEI = Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; BMI = Body mass inex, HDL = High density lipoprotein; ISMN = Isosorbide-5-monitrate; LDL = Low density lipoprotein; LVEF = Left ventricular ejection fraction; PCI = Percutaneous coronary intervention;
  2. *: P < 0.05